Foreword by Laurin Angermeier  ·  Neuroscience & Clinical Strategy Advisor, States of Mind

When I talk to someone who is considering their first facilitated psychedelic experience, the question I hear most often is not “which substance?” or “which retreat?” It is: “How do I know if someone is actually good at this?”

That question is harder to answer than it should be. The field has no universal licence, no governing body, and no shared standard for what competence looks like. What exists instead is a growing body of clinical research, a handful of serious training programmes, and a lot of practitioners describing themselves in ways that are difficult to verify. 

This guide was written to give you a practical framework to give you the right questions and the confidence to ask them. The eight areas it covers reflect what the research actually shows matters: the quality of the relationship, the rigour of preparation and integration, the safety structures around the session itself.

At PsyStandard, our goal is to make that evaluation process less opaque. The verification framework behind our directory is built on exactly these principles. Because the person holding the space shapes what happens inside it, and that deserves more than a listing.

— Laurin Angermeier

If you are considering a facilitated psychedelic experience, the biggest choice you will make is which psychedelic facilitator to work with. The person holding the process shapes what happens inside it, probably more than the substance. The problem is that no single credential tells you who is actually qualified. Psychedelic facilitation has no global certification body, no universal licence, and across most of Europe no regulated training standard at all. Oregon’s 2023 facilitator licence is one of the first state-issued credentials anywhere. Everywhere else, you are evaluating the person in front of you.

This guide covers how to choose a psychedelic facilitator: eight questions to ask before you book, plus the warning signs that should end the conversation.

What Is a Psychedelic Facilitator?

A psychedelic facilitator is a trained practitioner who guides a client through a psychedelic experience, supports preparation and integration, and maintains the conditions for safety during the session. A facilitator does not diagnose conditions, does not prescribe treatment, and does not conduct therapy in the clinical sense. The field spans both clinical practitioners — psychotherapists, psychiatrists, and nurses working within regulated frameworks — and non-clinical practitioners operating in harm reduction, coaching, or ceremonial contexts. What matters is understanding which kind of practitioner you are working with and what that means for your care.

The word sits in a broader field that also includes retreat centres and medical clinics. A retreat is a multi-day programme, usually in a group format, run by an organisation with several facilitators and a structured schedule. A medical clinic is a licensed healthcare setting where psychedelic-assisted therapy is delivered by credentialled clinicians under a specific regulatory framework, as in Oregon, Australia, or Switzerland. An individual facilitator typically works one-to-one or with very small groups.

Credentials alone will not tell you what you need to know. A fully qualified psychologist can be a poor facilitator, while someone without a clinical licence can run a safer process than many credentialled therapists. Training is necessary but not sufficient.

Why Choosing Carefully Matters

In non-clinical or unvetted settings, the likelihood of running into persistent psychological difficulties is harder to predict. A 2023 analysis in Scientific Reports documented 608 cases of lasting psychological difficulty following psychedelic experiences, most of them outside clinical settings [1]. The research does not say that risks vanish in vetted contexts, but it does say that the quality of the setting and the facilitator shifts the distribution of outcomes.

Researchers at Ohio State and Johns Hopkins looked at participants who had gone through psilocybin-assisted therapy for depression [2]. Those who rated a stronger working relationship with their facilitator showed greater reductions in depression scores up to twelve months later. The relationship mattered more at the end of treatment than at the start, which suggests the connection itself is part of how the therapy works, not just the drug. A 2022 Imperial College study found similar patterns [3].

This is why “listed” and “verified” are not the same thing. Many platforms publish contact details. Fewer examine who the person actually is, what they trained in, and how they work. The next section explains what substantive verification looks like.

8 Questions to Ask Before You Book

The most useful questions cover eight areas: training, legal context, screening, preparation, handling of difficulty during a session, integration support, informed consent, and professional peer standing. Serious practitioners expect these questions and welcome them. Treat the list as a framework for your own conversation. If a facilitator cannot speak substantively to most of these areas, keep looking.

1.  What is your training and background?

A good answer names a specific training programme, such as MAPS, CIIS, Fluence, Synthesis Institute, Polaris, or one of the state-approved curricula in Oregon and Colorado. It gives you total training hours and the number of supervised sessions the facilitator ran as part of their practicum. It should cover any clinical licences the person holds, such as psychotherapy, counselling, nursing, or medicine, and whether those are still active.

Oregon’s state licence is a useful benchmark: it requires at least 120 hours of core training and 40 hours of supervised practicum before anyone can legally work with clients [6]. Most jurisdictions have no comparable standard yet. That is why the answer you get should be detailed and verifiable rather than a vague reference to “years of experience.”

2.  What does your harm reduction framework look like — and how do you handle adverse events?

Harm reduction is not a single intervention — it is a philosophy that runs through every stage of the work. A serious answer covers how the facilitator approaches substance sourcing and transparency, contraindication screening, safety planning before the session, and what happens structurally if something goes wrong during or after it. Ask specifically: what protocols exist for acute psychological distress? Is there a medical contact or emergency plan? What does the follow-up process look like if a participant experiences lasting difficulty?

Adverse events are rare in well-structured settings, but they are not zero. A 2023 analysis in Scientific Reports documented 608 cases of lasting psychological difficulty following psychedelic experiences, most occurring outside clinical settings [1]. A facilitator who has thought seriously about harm reduction will be able to describe their framework concretely — not just reassure you that they have never had a problem. The absence of a clear answer here is itself a signal.

3.  How do you screen participants before a session?

A serious screening is the first harm reduction step in psychedelics work. It covers your medical history, your mental health history, any medications you currently take, and your current life situation. The medical side looks at things like heart conditions and severe liver or kidney problems. On the mental health side, a personal or first-degree family history of psychosis, schizophrenia, or bipolar I is typically disqualifying or requires specialist review. Medication review matters because some SSRIs reduce psilocybin’s effects, and lithium combined with psilocybin has been linked to rare but serious reactions [7].

A twenty-minute intake form is not screening. Expect at least one substantive conversation before any booking, and be prepared for the facilitator to ask to speak with your doctor or psychiatrist. A facilitator who screens seriously will sometimes decline to work with a given participant. That is a sign of professional care, not rejection.

4.  What does your preparation process look like?

Good psychedelic preparation happens across multiple sessions, not in a single call. Clinical protocols such as those used at Johns Hopkins involve three to five preparation sessions over several weeks, each typically 60 to 90 minutes long [8]. A well-run retreat compresses this into one or two video sessions before arrival plus on-site preparation in the day or two before the dosing session. Good preparation uses that time to build trust, clarify your intentions, explain what the substance is likely to feel like, and teach anchoring techniques for difficult moments.

A single thirty-minute intake call does not clear that bar. Preparation quality correlates with outcome quality, which is part of why serious clinical programmes treat it as integral to the intervention rather than administrative overhead.

5.  How do you handle psychological difficulties during a session?

Ask the facilitator to describe what they actually do when a client experiences acute anxiety, fear, or distress during a psychedelic session. A substantive answer follows established safety guidelines for psychedelic research and clinical practice [15]. It describes written protocols, grounding and anchoring techniques, the choice between verbal intervention and holding space, and the point at which medical help is called in. It also acknowledges that challenging experiences are not always a problem to solve. In a survey of 1,993 people, 39 percent reported difficult moments during a psilocybin experience, and many rated those moments as meaningful in retrospect [9].

A facilitator who says “we’ve never had any issues” has either not been paying attention or is not telling you the truth. Either way, that is a facilitator to avoid.

6.  What integration support do you offer after the experience?

The clinical standard involves three to six integration sessions spread over six to twelve weeks after the dosing session, with the first ideally within a week [8]. Good psychedelic integration covers reflection on the experience, translation of insights into concrete behaviour change, and modalities such as somatic work, internal family systems, journalling, or community sharing where appropriate [10].

The two to six weeks following a session appear to be a period of heightened psychological flexibility, when new patterns of thinking and behaviour can be more easily established [11]. That window closes. Structured integration work inside it is what translates insight from the session into lasting change outside it. A facilitator who offers only “call me if you need to” has not built an integration programme; they have left a phone number. Ask what happens in the first week, the first month, the first three months.

7.  What does informed consent look like in your practice?

Informed consent in psychedelic work happens in conversation, not on paper. It covers which substance you will take, what dose, from what source, and what it is likely to feel like. It covers the facilitator’s position on therapeutic touch, ranging from complete avoidance to limited supportive touch with negotiated rules. It covers your right to end the session at any point, within the practical limits of the substance’s effects.

A 2024 paper in the Canadian Journal of Psychiatry described this as “dynamic consent,” recognising that a client’s preferences can shift during a session and that the facilitator’s job is to anticipate that and build in checkpoints [12]. If a facilitator cannot tell you what is in the substance, or deflects questions about touch with “we will see how it feels,” informed consent is not functioning as it should.

8.  How are you embedded in professional peer structures?

Isolated practice is a safety and quality risk. Ask about current clinical supervision, peer consultation groups, membership in professional associations, and ongoing continuing education. A facilitator who has regular contact with other practitioners gets feedback on their work, catches blind spots earlier, and has colleagues to consult when difficult situations come up. A facilitator who works alone, without supervision and without a professional community, has no external check on their practice.

In the Netherlands organisations such as Guild of Guides are beginning to build formal peer structures for facilitation [13]. In the United States, state licensing in Oregon and Colorado requires continuing education. What matters is that some form of peer embedding exists, and that the facilitator can describe it specifically: who they meet with, how often, what they discuss.

Red Flags: What to Watch Out For

The eight questions above probe for quality directly. The patterns below describe red flags that disqualify a facilitator regardless of how other answers sound. Professional practice guidelines in the field document these as indicators of ethical and safety concerns [14].

Professional Conduct

• Pressure tactics. Artificial urgency, “limited spots,” or discounts tied to fast booking. A session requires readiness; a seller in a hurry is not a good sign.
• Specific outcome promises. “This will heal your depression” or “you will meet your true self” misrepresent what the research actually shows about psychedelic experiences.

Relational and Power Dynamics

• Boundary violations. Sexual remarks, romantic approaches, or suggestions of continuing the relationship outside the facilitator role. A recurring source of documented harm in the field.
• Isolation from your support system. “Don’t tell your therapist” or “this is between us” removes the professional accountability that good work requires.
• Spiritual dogma or guru positioning. The facilitator presents as a channel, wisdom keeper, or authority over your experience. Replaces your inner authority with theirs.

What Verification Actually Looks Like

Most directories list practitioners. Fewer verify them. The difference matters.

PsyStandard is a verification framework designed to make the distinction visible. Practitioners in the directory carry one of three badges, each reflecting a different level of assessment.

Listed · PsyStandard

Credentials and training background have been reviewed against PsyStandard interim verification criteria. A structured connection call has been passed and the practitioner’s ethical floor and accountability structure confirmed. Competency has not yet been independently assessed. This badge is valid for 12 months and non-renewable — practitioners must complete an observed practice assessment within that period or be delisted. It is an entry pathway, not a quality signal.

Verified · PsyStandard

Everything in the Listed tier, plus an independently assessed 60-minute observed mock session. The session is scored across multiple competency dimensions by two calibrated assessors. Three safety floors — boundaries, contraindications, and referral protocols — must be passed. The competency framework is informed by existing research and co-designed with experts in the field. Verified status is valid for two years and renewable, with full reassessment every four years. This is the core quality signal in the directory.

Verified · Profile Complete

Everything in the Verified tier, plus a completed specialist profile documenting modalities, populations served, therapeutic orientation, supervision arrangements, peer nominations, and continuing professional development. This tier functions as a matching layer — it powers filtered searches for clients with specific needs — rather than a higher quality designation. The verification standard is the same as the Verified tier.

What the badge does not say: 

PsyStandard badges are not certification (we assess observed competency, we do not certify curriculum completion), not approval (what a practitioner does in their own practice remains their professional responsibility), and not a safety guarantee (harm can occur even with verified practitioners — a harm governance protocol exists for reporting concerns).

Practitioners in the directory can be filtered by verification status. Verified practitioners appear above Listed practitioners in search results by default — not because they paid more, but because they have been independently assessed.

Summary

What you are looking for is a facilitator who can speak substantively across all eight areas: training, legal context, screening, preparation, handling of difficulty, integration, informed consent, and professional peer standing. A facilitator who answers these questions consistently and specifically has done the work. One who deflects on more than one or two is someone to keep searching past. The red flags above describe behaviours that should end the conversation regardless of how the other answers sound. Trust what you see across a full conversation, not what is promised in a single call.

Sources

[1] Bremler R, Katati N, Shergill P, Erritzoe D, Carhart-Harris RL. Case analysis of long-term negative psychological responses to psychedelics. Scientific Reports 2023;13:15998.

[2] Levin AW, et al. The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. PLOS ONE 2024;19(3):e0300501.

[3] Murphy R, et al. Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Frontiers in Pharmacology 2022;13:788155.

[4] Luoma JB, et al. Oregon’s Emerging Psilocybin Services Workforce. Journal of Psychoactive Drugs 2025.

[5] Netherlands Opium Act (Opiumwet), Ministerial Guidance on sclerotia exemption.

[6] Oregon Health Authority, Oregon Psilocybin Services. oregon.gov/oha

[7] Halman A, et al. Drug-drug interactions involving classic psychedelics. Journal of Psychopharmacology 2024;38(1):3-18.

[8] Johns Hopkins Center for Psychedelic and Consciousness Research, published clinical protocols.

[9] Carbonaro TM, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms. Journal of Psychopharmacology 2016;30(12):1268-1278.

[10] Bathje GJ, et al. Psychedelic integration: An analysis of the concept and its practice. Frontiers in Psychology 2022;13:824077.

[11] Watts R, Luoma JB. The use of the psychological flexibility model to support psychedelic assisted therapy. Journal of Contextual Behavioral Science 2020;15:92-102.

[12] Lee A, Rosenbaum D, Buchman DZ. Informed Consent to Psychedelic-Assisted Psychotherapy. Canadian Journal of Psychiatry 2024.

[13] Psychedelic Access and Research European Alliance (PAREA). parea.eu

[14] BrainFutures. Professional Practice Guidelines for Psychedelic-Assisted Therapy, August 2023.

[15] Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology 2008;22(6):603-620.